InMed Reports Second Quarter Fiscal 2023 Financial Results and Provides Business Update

February 18, 2023

https://www.globenewswire.com/news-release/2023/02/17/2610993/36215/en/InMed-Reports-Second-Quarter-Fiscal-2023-Financial-Results-and-Provides-Business-Update.html

VANCOUVER, British Columbia, Feb. 17, 2023 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq:INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today announced financial results for the second quarter of fiscal year 2023 which ended December 31, 2022.

Read more at globenewswire.com

Related news for (INM)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.